• SENSEX 72,472.33
    879.09 (+1.23%)
  • BANKNIFTY 55,256.65
    741.60 (+1.36%)
  • Adani Ports
    1,769.75 1,891.80(%)
  • GMR Airports
    92.17 115.60(%)
  • Anthem Bioscienc
    833.00 579.45(%)
  • Reliance Industries
    1,160.40 1,160.40(%)
  • Moneyview
    63.50 64.61(%)
  • Cupid
    368.05 368.05(%)
  • Life Insurance
    394.50 468.30(%)
  • TCS
    2,204.00 3,336.70(%)
  • NSE
    1,737.40 1,878.00(%)
  • Kotak Mah. Bank
    445.20 452.98(%)
  • Oil India
    441.95 395.75(%)
  • Kanohar Elect.
    1,095.35 672.05(%)
  • Hexaware Tech.
    574.45 808.40(%)
  • HDFC Bank
    709.90 1,020.35(%)
  • Tour. Fin. Corp.
    150.15 154.40(%)
  • Acme India
    232.05 232.05(%)
  • Colgate-Palmoliv
    1,867.45 2,329.85(%)
  • Swiggy
    232.30 232.30(%)
  • Max Healthcare
    915.00 1,221.10(%)
  • Petronet LNG
    295.30 326.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shree Ganesh Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71615.0
  • ISIN : INE414Y01015
678.65 -28 (-3.91%)
  • As on 09 Oct 2026 (EOD)

  • Today’s Low

    671.35

  • Today’s High

    719.85

  • Open

    719.85

  • Perv Close

    706.25

  • 52W Low

    477.05

  • 52W High

    749.85

Key Indicators

  • P/E(TTM)

    56.63

  • Mar.Cap (₹Cr.)

    871.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    126.98

  • Debt-Equity Ratio

    -3.91

  • AGM Date

    09-Oct-2026

  • EPS

    12.03

  • P/E Ratio

    56.63

Financials Ratios

  • Debt-Equity Ratio

    0.30

  • Mar.Cap (₹Cr.)

    871.23

  • RONW (%)

    23.02

  • ROCE (%)

    24.40

Score Board

  • Equity (₹ in Cr.)

    12.84

  • BV (₹)

    127.00

  • Sales( ₹ in Cr.)

    109.29

  • NP (in Cr.)

    16.70

  • NP Var(%)

    -26.0

  • Div%

    0.0

  • CPS (₹)

    21.20

  • EPS (₹)

    13.00

  • Traded Value (₹ in Lakhs)

    874.56

  • 52 Week High

    749.85

  • 52 Week Low

    477.05

  • Price BSE

    681.0

  • Price NSE

    679.00

  • Market Capital( in Cr.)

    874.56

  • P/C Ratio

    32.20

  • P/E Ratio

    52.40

  • Price Vs.BV

    13.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 109.29 108.60 125.90 91.36 71.29 49.08
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 109.29 108.60 125.90 91.36 71.29 49.08
Other Income 3.03 3.73 3.07 0.72 3.57 2.09
Stock Adjustments -0.96 1.52 4.88 0.69 0.40 3.97
Total Income 111.36 113.85 133.85 92.77 75.26 55.14
EXPENDITURE :            
Raw Materials 40.95 37.52 63.36 48.61 38.11 26.47
Power and Fuel Cost 5.77 7.89 6.39 4.91 4.25 1.34
Employee Cost 11.40 10.12 8.41 5.97 2.95 2.43
Other Manufacturing Expenses 3.73 3.44 0.80 0.51 0.44 1.30
Selling and Administration Expenses 10.61 11.27 9.42 7.02 7.62 7.56
Miscellaneous Expenses 0.86 0.66 0.60 1.60 0.39 0.31
Employee Benefit Expenses 11.40 10.12 8.41 5.97 2.95 2.43
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 73.31 70.91 88.97 68.61 53.77 39.41
Operating Profit 38.05 42.94 44.88 24.16 21.49 15.74
Interest 3.56 2.08 0.60 0.18 0.15 0.07
Gross Profit 34.49 40.86 44.28 23.98 21.34 15.67
Depreciation 10.47 9.57 6.11 3.74 3.34 2.73
Profit Before Tax 24.02 31.29 38.17 20.24 18.00 12.94
Current Tax 5.71 8.24 9.38 5.34 4.65 3.23
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.53 -0.04 0.67 -0.28 -0.04 -0.04
Reported Net Profit 17.77 23.10 28.12 15.18 13.40 9.75
Extraordinary Items 1.08 0.37 0.13 0.01 -0.03 0.00
Adjusted Net Profit 16.69 22.73 27.99 15.17 13.43 9.75
Adjustment below Net Profit 0.05 -0.01 0.05 0.00 -0.08 -1.54
P & L Balance brought forward 109.82 86.73 59.19 44.70 33.15 26.28
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.63 0.60 1.75 1.35
P & L Balance carried down 127.64 109.82 86.73 59.28 44.72 33.15
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 5.00 3.00 5.00 17.50
Dividend Per Share(Rs) 0.00 0.00 0.50 0.30 0.50 1.75
Earnings Per Share-Unit Curr 13.84 17.99 21.89 12.14 11.16 9.75
Earnings Per Share(Adj)-Unit Curr 13.84 17.99 21.89 12.14 11.08 8.07
Book Value 126.98 113.10 95.07 69.70 51.28 49.97
Book Value(Adj)-Unit Curr 126.98 113.10 95.07 69.70 50.92 41.35

Shareholding Pattern

  • Promoter Group

    72.84%

  • Public Share Holding

    27.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 10,568 0.08 10,568 1
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,339,961 72.75 9,339,961 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,350,529 72.84 9,350,529 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 143 0.00 143 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 67,054 0.52 67,054 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 67,197 0.52 67,197 3
2] Non Institution
Bodies Corporate 139,855 1.09 139,855 32
Clearing Members 47 0.00 47 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 75,221 0.59 75,221 210
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 39,104 0.30 39,104 97
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,453,603 11.32 1,453,603 26
Individuals holding nominal share capital up to Rs. 1 lakh 1,708,221 13.31 1,708,221 7,439
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 36 0.00 36 1
Others 3,807 0.03 3,807 3
Sub Total 3,419,894 26.64 3,419,894 7,811
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 12,837,620 100.00 12,837,620 7,822

Company Background

Shree Ganesh Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Shree Ganesh Remedies Ltd
  • BSE Code : 71615.0
  • ISIN : INE414Y01015

  • Incorporation Year

    1995

  • Registered Office

    Plot No 6011
    GIDC, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-2646-227777

  • FAX

    91-2646-226422

  • Chairman

    Chandubhai Kothia

  • Managing Director

    Chandubhai Kothia

  • Company Secretary

    Aditya Patel

  • Auditor

    Chaudhary Shah & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Shree Ganesh Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shree Ganesh Rem 681.25 112.32 109.29 56.63 14.57
Abbott India 25,999.85 7,217.19 6,929.05 34.22 43.78
Astrazeneca Phar 5,831.85 2,304.07 2,275.58 85.95 27.86
Glaxosmi. Pharma 2,539.80 3,932.76 3,790.20 40.57 58.17
Novartis India 2,047.55 393.10 354.33 51.71 15.94
Cipla 1,303.30 20,102.60 18,979.95 34.25 13.88
Bliss GVS Pharma 644.55 773.53 729.81 59.90 12.51
Fermenta Biotec. 517.50 474.15 450.25 24.16 18.77
Amrutanjan Healt 508.30 520.13 502.55 27.23 24.16
Guj. Themis Bio. 363.25 168.25 165.82 97.13 18.05
Ambalal Sarabhai 40.29 19.52 3.94 74.61 6.77